Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/1996
11/20/1996CN1033330C Calcium channel blocking polypeptides from theraphosidae aphonopelma
11/20/1996CN1033325C Preparation of antiinflammatory hydroxamic acids and N-hydroxyureas
11/19/1996US5576438 Lipoxygenase inhibitors; antiallergens, antiinflammatory agents
11/19/1996US5576327 Treatment of heart rhythym disorders by administration of 3-phenylsulfonyl-3, 7-diazabicyclo[3.3.1]nonane compounds
11/19/1996US5576325 Pyrrolyl-4h-pyranoquinolines
11/19/1996US5576323 Excitatory amino acid receptor antagonists
11/19/1996US5576322 Anti-ischemic 2,4-diaminoquinazolines
11/19/1996US5576321 Compounds having effects on serotonin-related systems
11/19/1996US5576318 For treatment of central nervous system disorders
11/19/1996US5576294 Polypeptides as enzyme inhibitors
11/19/1996US5576287 Method for treating acute renal disease and failure
11/19/1996CA2111460C Tetrahydrobenzazepine derivatives which inhibit lipoxygenase
11/19/1996CA2106200C Stereoselective preparation of substituted piperidines
11/19/1996CA1338722C Gamma-interferon for the treatment of vascular stenosis
11/18/1996CA2176415A1 Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ace and nep
11/17/1996CA2176553A1 Fluorine-containing benzoylguanidines
11/14/1996WO1996035712A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/14/1996WO1996035700A1 Saccharopeptides and derivatives thereof
11/14/1996WO1996035687A1 Peptidyl compounds and their therapeutic use
11/14/1996WO1996035677A1 Nitric oxide synthase inhibitors derived from cyclic amidines
11/14/1996WO1996035424A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects
11/14/1996WO1996035420A1 Use of(s)-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
11/14/1996WO1996031208A3 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
11/14/1996CA2220517A1 Aryl-imidazolines and aryl-imidazoles useful as alpha-2 adrenergic agonists without cardiovascular side effects
11/14/1996CA2220508A1 Saccharopeptides and derivatives thereof
11/14/1996CA2219973A1 Peptidyl compounds and their therapeutic use
11/14/1996CA2218360A1 Nitric oxide synthase inhibitors derived from cyclic amidines
11/14/1996CA2217859A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
11/13/1996EP0742216A2 Cyclic amide derivatives
11/13/1996EP0742214A1 Novel seco-D steroids active in the cardiovascular system and pharmaceutical compositions containing same
11/13/1996EP0742208A1 2-Ureido-benzamide derivatives
11/13/1996EP0741726A1 Substituted 3-arylidene-7-azaoxindole compounds and process for their preparation
11/13/1996EP0741715A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use
11/13/1996EP0741709A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
11/13/1996EP0741708A1 Cyanoguanidines as k-channel blockers
11/13/1996EP0741707A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
11/13/1996EP0741705A1 4-(2-(3-aryloxy-2-hydroxypropylamino alkyloxy)-5-nitrophenyl)-1,4-dihydropyridines as antihypertensive agents
11/13/1996EP0741704A1 Aralkylamino substituted azacyclic therapeutic agents
11/13/1996EP0741699A1 A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor
11/13/1996EP0741697A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
11/13/1996EP0741567A1 Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
11/13/1996CN1135758A Novel oligosaccharide-containing 14-aminosteroid compounds and novel diastereoselective aminosteroid process chemistry
11/13/1996CN1135757A Novel deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds
11/13/1996CN1135485A 2,9-di-substituted pur-6-ones compound
11/13/1996CN1135484A 3-alkylcarbonyl-thiadiazineone
11/13/1996CN1135480A Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound
11/13/1996CN1135358A Medicine for treatment of restenosis and arteriosclerosis
11/12/1996US5574190 Naphthyl compounds, intermediates, compositions, and methods
11/12/1996US5574071 Administering phenylalkylamino ketones
11/12/1996US5574070 Substituted guanidines having high binding to the sigma receptor and the use thereof
11/12/1996US5574069 Substituted benzenesulfonylureas and -thioureas- process for their preparation and their use as pharmaceuticals
11/12/1996US5574047 Methods of inhibiting imperfect tissue repair
11/12/1996US5574037 Modulated by sino-atrial node, antiischemic agent
11/12/1996US5574034 Treatment of immune diseases and excess cell proliferation, enzyme inhibitors
11/12/1996CA2174715A1 Seco-d steroids active on the cardiovascular system and pharmaceutical compositions containing same
11/12/1996CA2040319C Sulfonylamino substituted bicyclyl hydroxamic acid derivatives
11/12/1996CA2039249C Sulfonylphenyl-.beta.-d-thioxylosides, their method of preparation and their use in therapeutics
11/12/1996CA1338716C Thienyloxyalkylamine derivatives, process for their preparation and medicaments containing them
11/07/1996WO1996034948A1 Monoclonal antibody reactive with human-origin cetp and method of quantifying human-origin cetp
11/07/1996WO1996034943A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034867A1 PYRIDO[2,3-d]PYRIMIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
11/07/1996WO1996034864A1 Piperazino derivatives as neurokinin antagonists
11/07/1996WO1996034856A1 2-ureido-benzamide derivatives
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034849A1 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/07/1996CA2220156A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2194481A1 2-ureido-benzamide derivatives
11/06/1996EP0741187A2 Recombinant obese (Ob) proteins
11/06/1996EP0741139A1 Sulphuric acid esters of amino sugars
11/06/1996EP0741133A2 Adhesion receptor antagonists
11/06/1996EP0741128A2 Sulphuric acid esters of sugar alcohols for the inhibition of the migration and proliferation of smooth muscle cells of the vascular walls
11/06/1996EP0740939A1 Compositions for treatment and prophylaxis of atherosclerosis
11/06/1996EP0740937A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition
11/06/1996EP0740936A2 Use of benzopyran derivatives for the manufacture of medicaments for the treatment of diseases connected with the sodium independent Cl-/HCO3- exchanger
11/06/1996EP0740701A1 Mammalian monocyte chemoattractant protein receptors
11/06/1996EP0740668A1 Tetracyclic derivatives, process of preparation and use
11/06/1996EP0740655A1 Metalloproteinase inhibitors
11/06/1996EP0740653A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
11/06/1996EP0740652A1 Metalloproteinase inhibitors
11/06/1996EP0740649A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
11/06/1996EP0532629B1 1-piperidinyl alkanoylarylsulfonamide derivatives
11/06/1996CN1135221A Urethane-containing aminosteroid compounds
11/06/1996CN1135177A Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
11/06/1996CN1135176A Combination of progresterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for perio-and post menopausal women
11/06/1996CN1135161A Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds
11/06/1996CN1134938A Novel alkylated (hetero) cyclic compounds, process for their prepn. and pharmaceutical compositions contg. same
11/06/1996CN1134932A Substituted benzene sulfonyl urea and benzene sulfonyl thiourea and mfg. method and use as raw material for medicine
11/06/1996CA2175747A1 Benzopyrane derivatives used for preparing pharmaceutical compositions used in the treatment of pathology related to na+ independent cl-/hco3- exchanger
11/06/1996CA2175298A1 Recombinant obese (ob) proteins
11/06/1996CA2174583A1 Sulfuric acid esters of sugar alcohols
11/06/1996CA2174582A1 Sulphuric acid esters of amino-sugars
11/05/1996US5571942 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
11/05/1996US5571925 Angiotensin II antagonists
11/05/1996US5571843 Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof
11/05/1996US5571842 Perfluoroalkyl-substituted, benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
11/05/1996US5571840 Method for treating central nervous system ischemia
11/05/1996US5571834 Pharmaceutical composition useful for the treatment of cardiovascular diseases
1 ... 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 ... 1595